Novartis AG (NVS)
140.76
-0.18
(-0.12%)
USD |
NYSE |
Oct 06, 16:00
141.58
+0.82
(+0.59%)
After-Hours: 20:00
Novartis Market Cap : 257.66B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 257.98B |
| October 02, 2026 | 258.11B |
| October 01, 2026 | 258.20B |
| September 30, 2026 | 260.98B |
| September 29, 2026 | 266.73B |
| September 28, 2026 | 268.87B |
| September 25, 2026 | 266.27B |
| September 24, 2026 | 262.81B |
| September 23, 2026 | 261.24B |
| September 22, 2026 | 258.62B |
| September 21, 2026 | 258.07B |
| September 18, 2026 | 256.95B |
| September 17, 2026 | 257.96B |
| September 16, 2026 | 253.90B |
| September 15, 2026 | 253.75B |
| September 14, 2026 | 254.43B |
| September 11, 2026 | 251.08B |
| September 10, 2026 | 251.66B |
| September 09, 2026 | 251.66B |
| September 08, 2026 | 252.07B |
| September 04, 2026 | 292.87B |
| September 03, 2026 | 298.54B |
| September 02, 2026 | 297.39B |
| September 01, 2026 | 295.18B |
| August 31, 2026 | 278.35B |
| Date | Value |
|---|---|
| August 28, 2026 | 281.56B |
| August 27, 2026 | 283.09B |
| August 26, 2026 | 288.38B |
| August 25, 2026 | 292.85B |
| August 24, 2026 | 289.26B |
| August 21, 2026 | 290.80B |
| August 20, 2026 | 286.00B |
| August 19, 2026 | 293.46B |
| August 18, 2026 | 282.91B |
| August 17, 2026 | 278.19B |
| August 14, 2026 | 276.19B |
| August 13, 2026 | 277.73B |
| August 12, 2026 | 278.83B |
| August 11, 2026 | 283.02B |
| August 10, 2026 | 287.01B |
| August 07, 2026 | 286.17B |
| August 06, 2026 | 282.29B |
| August 05, 2026 | 282.71B |
| August 04, 2026 | 280.57B |
| August 03, 2026 | 281.30B |
| July 31, 2026 | 285.84B |
| July 30, 2026 | 290.03B |
| July 29, 2026 | 290.75B |
| July 28, 2026 | 292.61B |
| July 27, 2026 | 285.77B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 289.89B |
| AstraZeneca PLC | 491.86B |
| GSK Plc | 94.25B |
| Johnson & Johnson | 613.57B |
| Eli Lilly & Co. | 1.090T |
Market Cap Related Metrics
| PE Ratio | 21.23 |
| PS Ratio | 4.944 |
| Price to Book Value | 6.202 |
| Price to Free Cash Flow | 18.07 |
| Price | 140.76 |
| Earnings Yield | 4.71% |
| Operating PE Ratio | 16.72 |
| Normalized PE Ratio | 19.78 |